Supreme Court votes to allow ‘pay-for-delay’ generic drug deal challenges
The Supreme Court has ruled that deals made between pharmaceutical companies and their generic drug competition may be challenged.
News Distribution for Justice
The Supreme Court has ruled that deals made between pharmaceutical companies and their generic drug competition may be challenged.